PROTEIN C manufacturers and suppliers

PROTEIN C suppliers

PROTEIN C

CAS:: 42617-41-4

MF:

MW:: 0

Suppliers by country/region

Company Type

Properties

storage temp.: -20°C

solubility: H₂O: 1 mg/mL

form: lyophilized powder

Safety Information

Hazard Codes: B

Risk Statements: 36/37

Safety Statements: 36/37-36-26

WGK Germany: 3

Use

Drotrecogin alfa was introduced in the US as a new intravenous treatment for the reduction of mortality in adult patients with severe sepsis associated with acute organ dysfunction. Drotrecogin aifa is the first recombinant activated protein C expressed in human kidney 293 cells. Activated protein C1 an endogenous serine protease, acts as an antithrombotic via inhibition of factor Va and Vllla, promotes fibrinolysis via inactivation of plasminogen-activator inhibitor-1 and exerts an anti-inflammatory effect by inhibiting the production of inflammatory cytokines (tumor necrosis factor-alpha, interieukin-1 and 6) by monocytes. It was shown that the majority of patients with sepsis have reduced levels of activated protein C. In a baboon model of lethal E. coli sepsis, administration of activated protein C reduced mortality. In a phase III clinical trial, intravenous infusion of drotrecogin alfa at a dose of 24 μg/kg/h over 96 h significantly reduced the risk of death compared with placebo in patients with severe sepsis. However, an increased risk of serious bleeding has been associated with the administration of the drug.

You can find PROTEIN C suppliers, manufacturers, and distributors from countries such as United States, China and the Japan here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.